ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $35,000 | +84.2% | 21,062 | +13.4% | 0.00% | – |
Q1 2020 | $19,000 | -47.2% | 18,566 | -1.5% | 0.00% | – |
Q4 2019 | $36,000 | +227.3% | 18,845 | +72.2% | 0.00% | – |
Q3 2019 | $11,000 | -66.7% | 10,944 | -27.2% | 0.00% | – |
Q2 2019 | $33,000 | -81.6% | 15,026 | -37.9% | 0.00% | -100.0% |
Q4 2018 | $179,000 | – | 24,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |